Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label Study of Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis

NCT03264716 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03264716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label Study of Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2017
Completion date
September 11, 2018
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable colorectal liver metastasis